L., T., A., G., G., P., R., L., A., Z., E., L., . . . E., E. (2023). Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma.
Citación estilo ChicagoL., Trilla-Fuertes, et al. Sorting Transcriptomics Immune Information From Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients With Advanced Melanoma. 2023.
Cita MLAL., Trilla-Fuertes, et al. Sorting Transcriptomics Immune Information From Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients With Advanced Melanoma. 2023.
Precaución: Estas citas no son 100% exactas.